Your browser doesn't support javascript.
loading
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases.
Gagnon, Eloi; Pelletier, William; Gobeil, Émilie; Bourgault, Jérôme; Manikpurage, Hasanga D; Maltais-Payette, Ina; Abner, Erik; Taba, Nele; Esko, Tõnu; Mitchell, Patricia L; Ghodsian, Nooshin; Després, Jean-Pierre; Vohl, Marie-Claude; Tchernof, André; Thériault, Sébastien; Arsenault, Benoit J.
Afiliación
  • Gagnon E; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Pelletier W; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Gobeil É; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Bourgault J; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Manikpurage HD; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Maltais-Payette I; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Abner E; School of Nutrition, Université Laval, Québec, QC Canada.
  • Taba N; Estonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, Tartu, 51010 Estonia.
  • Esko T; Estonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, Tartu, 51010 Estonia.
  • Mitchell PL; Institute of Molecular and Cell Biology, University of Tartu, Riia 23, Tartu, 51,010 Estonia.
  • Ghodsian N; Estonian Genome Center, Institute of Genomics, University of Tartu, Riia 23b, Tartu, 51010 Estonia.
  • Després JP; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Vohl MC; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC Canada.
  • Tchernof A; VITAM - Centre de recherche en santé durable, Université Laval, Québec, QC Canada.
  • Thériault S; School of Nutrition, Université Laval, Québec, QC Canada.
  • Arsenault BJ; Centre NUTRISS, Institut sur la nutrition et les aliments fonctionnels, Université Laval, Québec, QC Canada.
Commun Med (Lond) ; 2: 130, 2022.
Article en En | MEDLINE | ID: mdl-36249462
ABSTRACT

Background:

Observational studies have linked adiposity and especially abdominal adiposity to liver fat accumulation and non-alcoholic fatty liver disease. These traits are also associated with type 2 diabetes and coronary artery disease but the causal factor(s) underlying these associations remain unexplored.

Methods:

We used a multivariable Mendelian randomization study design to determine whether body mass index and waist circumference were causally associated with non-alcoholic fatty liver disease using publicly available genome-wide association study summary statistics of the UK Biobank (n = 461,460) and of non-alcoholic fatty liver disease (8434 cases and 770,180 control). A multivariable Mendelian randomization study design was also used to determine the respective causal contributions of waist circumference and liver fat (n = 32,858) to type 2 diabetes and coronary artery disease.

Results:

Using multivariable Mendelian randomization we show that waist circumference increase non-alcoholic fatty liver disease risk even when accounting for body mass index (odd ratio per 1-standard deviation increase = 2.35 95% CI = 1.31-4.22, p = 4.2e-03), but body mass index does not increase non-alcoholic fatty liver disease risk when accounting for waist circumference (0.86 95% CI = 0.54-1.38, p = 5.4e-01). In multivariable Mendelian randomization analyses accounting for liver fat, waist circumference remains strongly associated with both type 2 diabetes (3.27 95% CI = 2.89-3.69, p = 3.8e-80) and coronary artery disease (1.66 95% CI = 1.54-1.8, p = 3.4e-37).

Conclusions:

These results identify waist circumference as a strong, independent, and causal contributor to non-alcoholic fatty liver disease, type 2 diabetes and coronary artery disease, thereby highlighting the importance of assessing body fat distribution for the prediction and prevention of cardiometabolic diseases.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Commun Med (Lond) Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Commun Med (Lond) Año: 2022 Tipo del documento: Article